Inflammation, insulin resistance, and atherosclerosis

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Inflammation Biology

Background:

• Atherosclerosis was historically viewed as passive lipid deposition, but is now understood as a dynamic, inflammatory process.
• Insulin resistance (IR), central to type 2 diabetes mellitus (DM), is linked to elevated inflammatory markers.
• These inflammatory factors may mediate the strong association between IR/DM and cardiovascular disease (CVD).

Purpose of the Study:

• To review the association between inflammation, IR, and atherosclerosis.
• To highlight shared inflammatory factors in IR and atherosclerotic processes.
• To discuss the determinants of inflammation in these conditions.

Main Methods:

• Literature review of studies on inflammation, IR, and atherosclerosis.
• Analysis of shared inflammatory markers in IR and CVD.
• Discussion of underlying inflammatory mechanisms.

Main Results:

• Atherosclerosis is an active, dynamic process involving inflammation.
• Inflammatory factors like C-reactive protein (CRP), plasminogen activator inhibitor-1 (PAI-1), and fibrinogen are associated with both IR and atherosclerosis.
• These shared factors suggest inflammation as a key link between IR/DM and CVD.

Conclusions:

• Inflammation plays a central role in the pathogenesis of atherosclerosis.
• Shared inflammatory pathways connect insulin resistance and type 2 diabetes mellitus with cardiovascular disease.
• Understanding these inflammatory determinants is crucial for managing atherosclerosis and related conditions.